Page last updated: 2024-11-02

pimobendan and Centriacinar Emphysema

pimobendan has been researched along with Centriacinar Emphysema in 1 studies

pimobendan: produces arterial & venous dilatation in dogs; structure given in first source

Research Excerpts

ExcerptRelevanceReference
"Pimobendan is a positive inotropic agent that dilates blood vessels and sensitizes the myocardium to calcium."6.68[Effects of pimobendan on pulmonary hypertension in patients with chronic pulmonary emphysema]. ( Fujikane, T; Matsumoto, H; Sasaki, N; Shimizu, T; Takahashi, M; Takahashi, T; Takeda, A; Tsuji, T; Yamazaki, Y, 1997)
"Pimobendan is a positive inotropic agent that dilates blood vessels and sensitizes the myocardium to calcium."2.68[Effects of pimobendan on pulmonary hypertension in patients with chronic pulmonary emphysema]. ( Fujikane, T; Matsumoto, H; Sasaki, N; Shimizu, T; Takahashi, M; Takahashi, T; Takeda, A; Tsuji, T; Yamazaki, Y, 1997)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yamazaki, Y1
Matsumoto, H1
Takeda, A1
Takahashi, T1
Sasaki, N1
Takahashi, M1
Tsuji, T1
Fujikane, T1
Shimizu, T1

Trials

1 trial available for pimobendan and Centriacinar Emphysema

ArticleYear
[Effects of pimobendan on pulmonary hypertension in patients with chronic pulmonary emphysema].
    Nihon Kyobu Shikkan Gakkai zasshi, 1997, Volume: 35, Issue:8

    Topics: Aged; Blood Pressure; Cardiac Output; Chronic Disease; Humans; Hypertension, Pulmonary; Male; Middle

1997